Supply updates

Last updated 25 May 2020

We commit to ensuring the quality, safety and reliable supply of our products. If the supply of our medicines or vaccines is disrupted in Australia we will publish details here.

At this unprecedented time, we are actively managing our global supply chains to minimise potential disruption, and we are monitoring the situation closely. We will put the needs of patients first at all times.

At present, with the exception of specific supply disruptions as outlined below, we have adequate stock in place in Australia.

We support the Government and Pharmacy industry's steps to introduce limits on dispensing and sales of prescription and over-the-counter medicines during the COVID-19 pandemic to ensure patients can access the medicines they need. 


Ventolin inhalers

(VENTOLIN INHALER CFC-Free Salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose)

Unprecedented and unpredictable high consumer demand for Ventolin (salbutamol) inhalers across Australia in March and April, is still impacting availability in some areas of the country at a pharmacy level.

We now have good stock levels of Ventolin inhalers, but we still have allocation procedures in place with our pharmacy wholesalers to make sure supplies are distributed to where they are needed. In partnership with wholesalers we are prioritising supply to hospital pharmacies; all pharmacies should contact their usual wholesaler for supply-related questions.  


Flixotide (fluticasone propionate) 0.5 mg/2 mL nebules

Flixotide 0.5 mg/2 mL nebules are currently unavailable due to high global demand. Supply in Australia is expected to recommence in February 2021.  Please consult your healthcare professional should you require an alternative.


Herpes zoster vaccine

GSK’s herpes zoster vaccine, Shingrix, is not available in Australia. There is currently no confirmed timing for the supply of Shingrix to Australia.


Please visit the TGA website for ongoing updates to supply.

For more information on GSK's medicines or vaccines, please contact GSK medical information on 1800 033 109.